Multicenter Clinical Trial of Cefoperazone Sodium in the United States
- 1 July 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (1) , 35-41
- https://doi.org/10.1016/s0002-9343(84)80094-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adverse Effects of New CephalosporinsAnnals of Internal Medicine, 1983
- Pharmacokinetics of Cefoperazone in Patients with Normal and Impaired Hepatic and Renal FunctionClinical Infectious Diseases, 1983
- Cefoperazone Therapy for Obstetric and Gynecologic InfectionsClinical Infectious Diseases, 1983
- Cefoperazone for the Treatment of Acute Urinary Tract Infection: Multicentered Comparative and Noncomparative StudiesClinical Infectious Diseases, 1983
- Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro CharacteristicsClinical Infectious Diseases, 1983
- Characterization of beta-lactamase induction in Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1983
- GASTROINTESTINAL REACTIONS TO CEFOPERAZONEThe Lancet, 1982
- GASTROINTESTINAL REACTIONS TO CEFOPERAZONEThe Lancet, 1981
- Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1980
- In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporinAntimicrobial Agents and Chemotherapy, 1979